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Abstract
Background: High body iron store has been associated with an increased risk of type 2 diabetes (T2D); it remains unknown
whether the genetic variants related to body iron status affect T2D risk. We aimed at comprehensively investigating the
associations between the genetic variants related to body iron status and the T2D risk.
Methodology/Principal Findings: Six common SNPs related to body iron status from recent genome-wide association
(GWA) studies were determined in the Nurses’ Health Study (NHS; 1,467 diabetic cases and 1,754 controls) and the Health
Professionals Follow-up Study (HPFS; 1,124, diabetic cases and 1,298 controls). Plasma levels of ferritin, soluble transferrin
receptor (sTfR), and transferrin were measured in NHS. Significant associations were observed for loci in TPMRSS6 with sTfR
(P=3.47610
26), TF with transferrin (P=0.0002 to 1.72610
210); and HFE with ferritin (P=0.017 to 1.6610
28), sTfR (P=0.007
to 7.9610
26), and transferrin (P=0.006 to 0.0007). The six SNPs together explained 5.7%, 2.7%, and 13.3% of the variation in
plasma levels of ferritin, sTfR, and transferrin. After adjustment for the conventional risk factors, the T allele of SNP rs855791
in the TPMRSS6 gene was significantly associated with a 19% decreased risk of T2D (OR=0.81; 95% CI=0.66–0.98; P=0.03)
in men. Multiple tests attenuated this significant association to null. No associations were observed in women. SNPs at HFE
and TF were not associated with diabetes risk in either sex. Dietary iron intake did not modify the associations of the newly
identified loci with diabetes risk.
Conclusions/Significance: The newly identified iron-related SNP rs855791 in TPMRSS6 was nominally associated with a
decreased risk of T2D in men but not in women. The apparent differences by gender warrant further study.
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Introduction
Iron is a redox-active transitional metal and a strong pro-oxidant
that can catalyze the formation of free radicals and subsequent the
production of reactive oxygen species (ROS), which have been
implicatedintheetiologyoftype2diabetes(T2D)[1,2].Prospective
epidemiology studies have shown consistent associations between
bodyironstore,assessedbyserumferritinortransferrinreceptorsto
ferritin ratio, and an increased risk ofT2D [3–7].
Sequence variations in HFE gene have been associated with
excess body iron store [8,9]. In several recent genome-wide
association (GWA) studies, variants in transferrin (TF) and
TMPRSS6 genes were also found to be related to body iron status
[9,10]. Given the observed relation between body iron store and
diabetes risk, one may hypothesize that the body iron store-
associated genetic variants may predispose to an increased risk of
T2D. Recently one study investigated the associations between the
gene polymorphisms in transferrin receptor gene and T2D [11],
however, no studies have comprehensively examined the associa-
tions between the newly identified variants for body iron status and
T2D.
Therefore, in the present study we aimed to examine the
associations of the reported genetic variants for body iron store
(ferritin, soluble transferrin receptor [sTfR], and transferrin) with
T2D risk in two nested case-control studies. In our previous study,
we found dietary heme iron intake modified the genetic effects of
HFE variants on T2D risk [12]. In this study, we expanded to
assess the interactions between dietary heme iron intake and other
iron-associated SNPs in relation to T2D risk.
Results
Baseline Characteristics of Diabetic Cases and Controls
Table 1 presents the demographic and characteristics of
participants at baseline. T2D cases had a significantly higher BMI
and higher prevalence of family history of diabetes than controls.
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40919Also, T2D cases engaged in less physical activity and were more
likely to smoke than controls in both men and women. Among
women, T2D cases were more likely to be postmenopausal. T2D
cases in men and women both consumed more heme iron than
controls. In NHS, the levels of ferritin, sTfR and transferrin were
higher in cases than those in controls (P,0.05). There were no
significant differences in use of iron supplement between cases and
controls in both NHS and HPFS (P=0.13 and 0.31 respectively).
Associations between SNPs in TPMRSS6, HFE, and TF
Genes and Body Iron Status
SNP rs855791 in TPMRSS6 gene was significantly associated
with high sTfR levels and sTfR : ferritin ratio (P=3.47610
26 and
0.01) and marginally associated with low ferritin levels (P=0.068),
but was not associated with transferrin levels (P=0.13). Both
rs1799945 and rs1800562 in HFE gene were associated with
ferritin (P=0.017 and 1.6610
28), sTfR (P=7.9610
26 and 0.007),
and transferrin (P=0.006 and 0.0007) levels. SNPs of rs3811647
and rs1799852 in TF gene were associated with transferrin levels
(P=1.72610
210 and 0.0002.); However, SNP rs2280673 in TF
gene was not associated with transferrin levels but was significantly
associated with low sTfR: ferritin ratio (P=0.01) (Table 2). The
six SNPs together explained 5.7%, 2.7%, 13.3%, and 3.9% of
variations of plasma levels of ferritin, sTfR, and transferrin, and
sTfR : ferritin ratio, respectively.
Body Iron Status-associated Genetic Variants and T2D
Risk
Table 3 presents the genotype frequency of the six SNPs in
cases and controls respectively and the associations between the
variants related to body iron status and T2D risk. The minor allele
frequency of the six SNPs in the present study was similar as those
reported (http://www.ncbi.nlm.nih.gov/snp). T allele of SNP
rs855791 in TPMRSS6 gene was nominally and significantly
associated with a decreased risk of T2D in HPFS (OR=0.81; 95%
CI=0.66–0.98; P=0.03) after adjustment for covariates; however,
the SNP was not associated with T2D in the NHS. Because the
body iron stores especially ferritin levels can be influenced by
menopause status [13], we analyzed the associations of SNP
rs855791 with T2D stratified by menopause status in NHS. We
found that carriers of T allele did not significantly associate with
risk of T2D in pre-menopause women (OR=1.18; 95%
CI=0.93–1.51; P=0.17) and in post-menopause women
(OR=0.92; 95% CI=0.65–1.30; P=0.63); and the interaction
with menopause status was not significant (P=0.24). No significant
associations were found for other five SNPs with T2D risk. After
multiple tests, the association between the SNP rs855791 with
T2D risk was not significant. Exclusion of iron supplement users
did not materially change the associations between these SNPs and
the risk T2D in both NHS and HPFS.
We further examined the combined effects of the iron-related
SNPs on T2D risk. The results indicated that the GRS was
associated with higher risk of T2D in men. Subjects in the highest
tertile of the GRS had a 27% increased risk of T2D (95% CI:
1.05–1.53; P=0.01), compared with those in the lowest tertile
(Figure 1). The OR (95% CI) for T2D associated with each point
scored, corresponding to one risk allele, was 1.06 (1.01–1.12;
P=0.03). Adjusted for lifestyle risk factors except BMI did not
alter the results. Further adjustment for BMI attenuated the
associations to marginal significance. The GRS was not associated
with T2D risk in women (data not shown).
Table 1. Risk factor characteristics of T2D cases and controls at baseline in NHS and HPFS*.
Variables NHS HPFS
T2D (n=1467)
Controls
(n=1754) P Value
{ T2D (n=1124)
Controls
(n=1298) P Value
{
Age, y 43.5(6.7) 43.1 (6.8) 0.07 55 (8.6) 55 (8.4) 0.65
BMI, kg/m
2 27.4 (5.0) 23.5 (3.9) ,0.0001 27.8 (4.0) 25.0 (2.7) ,0.0001
Family history of diabetes, % 49.5 22.1 ,0.0001 33.4 13.6 ,0.0001
Current smoking, % 29.4 20.9 ,0.0001 12.1 7.6 ,0.0001
Alcohol intake, g/d 4.4 (9.1) 6.6 (10.0) ,0.0001 11.2 (16.2) 12.1 (15.9) 0.19
Physical activity
{ 3.7 (2.8) 4.1 (2.9) 0.0005 14.6 (19.0) 21.1 (25.2) ,0.0001
Current PMH users, % 29.2 28.9 0.90 – – –
Postmenopausal, % 35.7 30.6 0.002 – – –
P:S ratio 0.34 (0.12) 0.35 (0.14) 0.26 0.55 (0.19) 0.58 (0.21) 0.004
Trans-fat intake, g/d 4.1 (1.3) 4.0 (1.3) 0.11 2.9 (1.0) 2.8 (1.1) 0.15
Cereal fiber intake, g/d 2.5 (1.5) 2.6 (1.6) 0.05 5.6 (3.3) 6.3 (4.8) 0.0001
Total energy intake, kcal/d 1611 (520) 1572 (488) 0.04 2100 (652) 2083 (619) 0.49
Total iron intake (mg/d) 17.5 (10.9) 17.8 (11.1) 0.51 20.0 (10.3) 20.7 (11.2) 0.13
Heme iron intake (mg/d) 1.12 (0.35) 1.04 (0.35) ,0.0001 1.29 (0.42) 1.15 (0.42) ,0.0001
Use of iron supplement, % 3.71 4.87 0.13 2.12 2.80 0.31
Ferritin (ng/ml) 105.2(101.2) 72.0 (72.1) ,0.0001 – – –
sTfR (mg/L) 3.38 (1.08) 3.19 (1.07) 0.006 – – –
Transferrin (mg/dl) 275.8 (45.6) 264.7(45.4) 0.01 – – –
*Values are means (SD) unless otherwise indicated. BMI = body mass index; PMH = post-menopausal hormone.
{Test of differences between cases and controls: x2 for categorical and T-tests for continuous variables.
{Metabolic equivalent task hours/wk for men in HPFS and hours/wk for women in NHS.
doi:10.1371/journal.pone.0040919.t001
Genetic Variation, Iron Status, and Diabetes
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Risk
In our previous analyses, we found genetic variants in HFE gene
interacted with heme iron intakes in relation to T2D risk [12]. In
the present study we examined the interactions of heme iron
intake with SNPs in other two loci TPMRSS6 and TF, but did not
find significant interactions in either men or women (data not
shown).
Discussion
In this study we confirmed that the recently identified SNPs in
TPMRSS6 and TF genes were associated with plasma biomarkers
for body iron store, sTfR and transferrin [9,10]. We found SNP
rs855791 in TMPRSS6 gene was associated with lower risk of T2D
in men but not in women. Multiple tests attenuated this significant
association to null. No significant interactions between the newly
identified SNPs and heme iron intake were observed in relation to
T2D risk.
The iron-T2D association has been extensively investigated. It
was found that 53–80% of patients with haemochromatosis, an
autosomal-recessive disorder with iron overload, developed
diabetes [14]. Evidences from the epidemiological studies in the
general population also support the relation between excess body
iron store and an increased risk of T2D [3–7]. Genetic variants in
HFE genes, C282Y (rs1800562) and H63D (rs1799945), have been
related to high body iron store [8,9]. However, in our previous
meta-analysis, we found that these variants were not associated
with T2D risk [12].
A recent GWA study found a nonsynonymous variant rs855791
in TMPRSS6 gene was associated with several indicators of body
iron status including serum iron, transferrin saturation, and ferritin
[10]. TMPRSS6, a transmembrane serine protease, plays a key
role in iron homeostasis by inhibiting the production of hepatic
hepcidin [15], and then influences the intestinal iron absorption
and the release of iron from cellular stores [16]. We demonstrated
the T allele of SNP rs855791 was associated with lower ferrtin and
higher sTfR levels and sTfR : ferritin ratio and this allele was
related to a decreased risk of T2D only in men. However, after
multiple tests, this association was not significant. This might be
due to the small sample size and the weak effects of the SNP on
T2D risk. Menstruation in women causes iron loss, which might
explain the difference in the genetic associations with T2D
between men and women. In fact, in our present study the post-
menopause women had higher levels of plasma ferritin
(111.0699.8 vs 79.1682.9 ng/ml; P,0.001) than pre-menopause
women. Among post-menopause women the T allele was not
significantly associated with risk of T2D; however, the effect
direction of this allele was in line with the observations in men.
The significant associations between TF variants and plasma
transferrin levels were consistent with the results in a GWA study
[9]. Transferrin has been associated with insulin resistance,
through increasing the rate of adipocyte lipolysis and circulating
free fatty acid [17]. However, we did not find associations between
the TF SNPs and T2D risk.
The null-associations between body iron-associated genetic
variants and T2D can be explained in several ways. First, the six
SNPs explained only a very small proportion of the variance in
body iron store. Therefore the weak association between the
genetic markers and T2D would be expected. Second, although
both the NHS and HPFS dataset had more than 80% power to
detect SNPs with odds ratio .1.4, given an a of 0.05 and allele
frequency of 0.10, our study might be underpowered for detecting
weaker associations. The NHS dataset only has 60% power to
detect genetic odds ratio of 1.2 for SNPs with MAFs equal to 0.10,
at the 5% significance level; for the HPFS dataset the power is
47%. Finally, inflammation might influence the findings in the
present study. Ferritin is believed to be influenced by inflamma-
tion. sTfR might also be regulated by inflammatory cytokines [18]
and insulin [19]. Although some studies found that the iron-
diabetes associations were independent of inflammation, it is still
remained to investigate in future studies. Especially, there is
evidence indicating that subunits of ferritin may be a better
biomarker than ferritin for assessing body iron status and that the
ratio of H:L-ferritin subunit levels can help to distinguish the
inflammation-induced or excessive iron-induced elevation of
ferritin [20].
Our data did support an additive effect of the variants at the
three loci HFE, TMPRSS6, and TF on T2D risk. The GRS
combining these genetic variants was associated with an increased
risk of T2D in men. Adjustment for the potential risk factors
especially BMI attenuated the associations of the iron-related GRS
and T2D risk, indicating that BMI might partially explain these
associations. However, the underlying mechanism remained to be
elucidated in further studies. We did not find the associations of
GRS and T2D risk in women. It might be due to the gender
difference as discussed above.
In our earlier analyses, we reported that the genetic variants in
HFE gene interacted with heme iron intake in relation to T2D
[12]. However, we did not find significant interactions between the
newly identified SNPs of TMPRSS6 and TF genes and heme iron
on diabetes risk. These observations suggest that the effects of the
SNPs in TMPRSS6 and TF genes on T2D risk are not modified by
Table 2. Associations between body iron status and the SNPs in TPMRSS6, HFE, and TF genes in NHS.
SNPs* Gene Ferritin (ng/ml) sTfR (mg/L) sTfR: ferritin ratio Transferrin (mg/dl)
b se P b se P b se P b se P
rs855791 T/C TPMRSS6 26.41 3.21 0.068 0.17 0.04 3.47E-6 16.5 7.0 0.01 4.33 2.85 0.13
rs1799945 C/G HFE 28.82 4.27 0.017 0.20 0.05 7.9E-6 24 9.5 0.04 11.43 3.87 0.006
rs1800562 A/G HFE 43.4 6.06 1.6E-8 20.13 0.07 0.007 222.3 13.4 0.08 216.38 4.46 0.0007
rs3811647 A/G TF 4.41 3.33 0.42 20.03 0.03 0.65 25.7 7.4 0.58 17.64 2.89 1.72E-10
rs1799852 T/C TF 25.59 5.12 0.18 0.04 0.06 0.72 17.1 11.2 0.12 213.17 4.50 0.0002
rs2280673 A/C TF 2.31 3.54 0.27 20.06 0.04 0.24 219.6 7.8 0.01 2.32 3.16 0.51
*the first allele of each SNP is effect allele.
doi:10.1371/journal.pone.0040919.t002
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PLoS ONE | www.plosone.org 4 July 2012 | Volume 7 | Issue 7 | e40919dietary iron intakes. The failure in identifying gene-diet interac-
tions may also due to the low power of the study.
Our study samples are highly homogeneous by only including
Caucasians with European ancestry. Our GWA analyses indicate
that the associations in these samples are not affected by
population stratification [21]. It remains to be determined whether
our findings are applicable to other populations. Another issue is
that some of our control subjects may have undiagnosed diabetes,
which might bias our results toward the null.
However, because the participants in our study are health
professionals and our previous study also showed that the
undiagnosed diabetes prevalence was low (approximately 2%)
[22], it might not appreciably affect our results.
In summary, we demonstrated associations between newly
identified genetic markers in TPMRSS6 and TF genes and body
iron stores, and found that SNP rs855791 in TPMRSS6 was
nominally associated with a decreased risk of T2D in men. Future
studies are needed to investigate the association of these iron
related variants and T2D risk in larger studies and in different
populations, as well as to elucidate potential gender difference in
the genetic effects.
Methods
Study Population
The NHS was established with the recruitment of 121,700
female registered nurses (aged 30–55 years) and residing in 11
large U.S. states completed a mailed questionnaire on their
medical history and lifestyle characteristics [23]. Beginning in
1980, dietary information has been updated every 2 to 4 years
using validated semi-quantitative food frequency questionnaires
(FFQs). Every two years, follow-up questionnaires have been sent
to update information on potential risk factors and lifestyle
information and to identify newly diagnosed cases of T2D and
other diseases [24]. The HPFS began in 1986 when 51 529 male
U.S. health professionals (aged 40–75 years) answered a detailed
questionnaire that included a comprehensive diet survey, and
items on lifestyle practice and medical history [25]. The cohort is
followed through biennial mailed questionnaire. Dietary informa-
tion is updated every four years [26]. Blood was collected from a
total of 32 826 NHS members between 1989 and 1990 and from
18 159 HPFS members between 1993 and 1999.
Subjects for the present study were selected from those who
provided blood samples using a nested case-control study design
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Figure 1. Associations between tertiles of genetic risk score
and type 2 diabetes risk in HPFS.
doi:10.1371/journal.pone.0040919.g001
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provided blood samples were generally similar to those who did
not. T2D cases were identified by self-report methods that were
confirmed with a validated supplementary questionnaire [29,30].
For cases before 1998 cycle, we used the National Diabetes Data
Group criteria [31] to define diabetes. The validity of this method
has been established [32]. We used the 1997 ADA diagnostic
criteria for diabetes diagnoses from 1998 onwards [33]. Among
the diabetes cases, a total of 98% of self-reported diabetes cases
were confirmed by medical records review in both NHS and
HPFS cohorts [29]. Controls were free of diabetes at the time the
case diagnosis and remained unaffected through follow- up till
2006. All participants provided written informed consent, and the
study was approved by the Human Research Committee at the
Brigham and Women’s Hospital, Boston.
Assessment of Covariates
Information about medical history, anthropometrical data,
lifestyle factors, and family history of diabetes in first-degree
relatives was derived from the baseline questionnaires [25,34].
BMI was calculated as weight in kilograms divided by the square
of height in meters (kg/m
2). For men, physical activity was
expressed as metabolic equivalent task (MET) hours of moderate
to vigorous exercise per week and was calculated by using the
reported time spent on various activities, weighting each activity
by its intensity level. For women, physical activity was expressed as
hours per week because MET was not measured at baseline in the
NHS. Self-administered questionnaires about body weight and
physical activity have been validated as described previously
[35,36]. Energy-adjusted intakes of heme iron (mg/d) were
calculated based on FFQs. We used the average intakes of
baseline dietary heme iron from the 1980 and 1984 questionnaires
in NHS and 1986 and 1990 questionnaires in HPFS for gene-
dietary heme iron interaction analysis. The correlation coefficient
for energy-adjusted total dietary iron intake from the FFQ and two
1-week diet records spaced 6 months apart was 0.60 after
adjustment for within-person variability in daily intake [24]. In
addition, heme iron consumption based on the FFQ has been
shown to be related to plasma ferritin levels in NHS [37].
DNA Extraction, Single Nucleotide Polymorphisms (SNPs)
Selection and Genotyping Methods
In the NHS nested case-control study, 67.8% blood samples
were obtained after 8-hour overnight fasting; in HPFS, it is 59.0%.
DNA was extracted from the buffy coat fraction of centrifuged
blood using a QIAmp blood kit (Qiagen, Chatsworth, CA). A
genome-wide scan was conducted using the Affymetrix Genome-
Wide Human 6.0 array and the Birdseed calling algorithm [21].
The quality control of genotyping and related analysis methods for
our GWA study were described previously [21]. In this study, six
SNPs related to iron stores, including H63D (rs1799945) and
C282Y (s1800562) in HFE gene, rs855791 in TPMRSS6 gene [10],
and rs3811647, rs1799852, and rs2280673 in TF gene [9] were
extracted from the genome-wide scans. The six SNPs did not
significantly deviate from Hardy-Weinberg equilibrium (HWE) in
controls in either NHS or HPFS after adjustment for multiple
testing (P.0.008: a=0.05/6 SNPs).
Determinant of Plasma Levels of Biochemical Markers in
NHS
The iron status biomarkers were measured in NHS. Blood
samples in NHS were collected in1989 and 1990 [38]. Concentra-
tions of ferritin and transferrin receptors were measured by a
particle-enhanced immunoturbidimetric assay using the Hitachi
911 analyzer (Roche Diagnostics, Indianapolis, IN) [12]. Transfer-
rin was measured by an immunoturbidimetric assay using the
Hitachi917analyzerandRocheDiagnosticsreagents(Indianapolis,
IN). To minimize bias and interassay variation, study samples were
selectedfromrandomlyorderedcase-controlpairsinmeasurement.
The coefficients of variation for ferritin, transferrin receptors, and
transferrin were 3.75%, 8.4%, and 6.0% respectively.
Statistical Analyses
Deviations from HWE were assessed by chi-square tests. We
used logistic regression to estimate ORs for T2D risk, adjusting for
age (in years), BMI (,23.0, 23.0–24.9, 25.0–29.9, 30.0–34.9, or
$35.0 kg/m
2 ), family history of diabetes (yes, no), smoking
(never, past, current), alcohol intake (nondrinker or drinker [0.1–
4.9, 5.0–9.9, 10.0–14.9, or $15.0 g/day]), menopausal status
[pre- or post-menopausal (never, past, or current hormone use);
women only], quintiles of physical activity, and quintiles of energy
adjusted P:S ratio, trans-fat and cereal fiber intakes. Power
calculations were performed using Quanto 1.2.3 (http://hydra.
usc.edu/gxe).
A genetic risk score (GRS) was calculated by summing up the
number of alleles of the six variants associated with higher levels of
markers of body iron. Interactions between SNPs and the dietary
heme iron intake were assessed by entering the cross-product of
the two variables into the model. To normalize the distributions,
plasma ferritin, sTfR, and transferrin were inverse normal
transformed. We used R
2, which was the difference of model
sum of squares between models with and without the SNPs of
interest divided by the corrected total sum of squares of the full
model, to calculate the percentage of the variance of the
biomarkers that were explained by the SNPs. Because multiple
variants were chosen to be investigated in the present study, we
used the Bonferroni’s correction to do the multiple comparisons
[39]. The SAS statistical package was used for the analyses (SAS,
version 9.0 for UNIX). All P values are two sided.
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